Establishing Humanized Mouse Model for EBV
Corresponding Organization : Louisiana State University Health Sciences Center Shreveport
Variable analysis
- Virus type (P3HR1, B95.8 or AG876)
- Virus dose (20,000 infectious units for AG876 and B95.8, 500,000 to 1 million infectious units for P3HR1)
- Tumor development
- Survival of mice (maximum of 92 days after injection or until moribund)
- Age of NSG mice (6- to 10-week-old)
- Cell type (mononuclear cells isolated from human umbilical cord blood)
- Cell count (minimum of 10 million cells injected intraperitoneally)
- Infection duration (1.5 hours at 37°C)
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!